ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Gates, Bloomberg Fund Project To Reduce Tobacco Use.

July 25, 2008

Long-time NCI Spokesman Paul Van Nevel Dies at 75

August 9, 2013

New Journal Examines Claims Of Proponents Of Alternative Medicine

October 24, 1997

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

December 31, 2004

NCI Staff Suggest New Community Oncology, Pain Control, Nurse, Pathology Center Projects

May 13, 1977

Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher

May 27, 1994